Any feedback?
Please rate this page
(literature.php)
(0/150)

BRENDA support

Literature summary extracted from

  • Braga-Silva, L.A.; Mogami, S.S.; Valle, R.S.; Silva-Neto, I.D.; Santos, A.L.
    Multiple effects of amprenavir against Candida albicans (2010), FEMS Yeast Res., 10, 221-224.
    View publication on PubMed

Inhibitors

EC Number Inhibitors Comment Organism Structure
3.4.23.24 amprenavir most effective inhibitor of Sap2, about 92% inhibition at 0.1 mM Candida albicans
3.4.23.24 indinavir
-
 Candida albicans
3.4.23.24 lopinavir
-
 Candida albicans
3.4.23.24 nelfinavir
-
 Candida albicans
3.4.23.24 ritonavir
-
 Candida albicans
3.4.23.24 saquinavir
-
 Candida albicans

Organism

EC Number Organism UniProt Comment Textmining
3.4.23.24 Candida albicans
-
-
-
3.4.23.24 Candida albicans 11
-
-
-

Substrates and Products (Substrate)

EC Number Substrates Comment Substrates Organism Products Comment (Products) Rev. Reac.
3.4.23.24 Bovine serum albumin + H2O
-
 Candida albicans ?
-
 ?
3.4.23.24 Bovine serum albumin + H2O
-
 Candida albicans 11 ?
-
 ?

Synonyms

EC Number Synonyms Comment Organism
3.4.23.24 SAP2
-
 Candida albicans
3.4.23.24 secreted aspartyl peptidase
-
 Candida albicans